4//SEC Filing
Tadvalkar Laura 4
Accession 0001610618-24-000093
CIK 0001610618other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 4:38 PM ET
Size
6.1 KB
Accession
0001610618-24-000093
Insider Transaction Report
Form 4
Tadvalkar Laura
Director
Transactions
- Award
Stock Option (right to buy)
2024-07-18+2,125→ 2,125 totalExercise: $12.64Exp: 2034-07-17→ Common Stock (2,125 underlying)
Footnotes (2)
- [F1]The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2025 annual meeting of stockholders.
- [F2]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the stock option, which will offset advisory fees owed by the Fund to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0002020464
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 4:38 PM ET
- Size
- 6.1 KB